Skip to main content
NCBI home page
Gut logoLink to Gut
. 1970 Dec;11(12):1043–1048. doi: 10.1136/gut.11.12.1043

Lactulose.

S G Elkington
PMCID: PMC1553161  PMID: 4929274

Full text

PDF
1043

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARTMAN E. L., WISE R. A. Hypokalemia in liver cell failure. Am J Med. 1953 Oct;15(4):459–467. doi: 10.1016/0002-9343(53)90136-3. [DOI] [PubMed] [Google Scholar]
  2. BROMBERG P. A., ROBIN E. D., FORKNER C. E., Jr The existence of ammonia in blood in vivo with observations on the significance of the NH4 plus minus NH3 system. J Clin Invest. 1960 Feb;39:332–341. doi: 10.1172/JCI104044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bircher J. Die Behandlung des chronischen Coma hepaticum mit Laktulose. Ther Umsch. 1969 May;26(5):275–277. [PubMed] [Google Scholar]
  4. Bircher J., Haemmerli U. P., Williams R. Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium. Gastroenterology. 1970 Apr;58(4):595–597. [PubMed] [Google Scholar]
  5. Bircher J., Haemmerli U. P., Williams R. Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium. Gastroenterology. 1970 Apr;58(4):595–597. [PubMed] [Google Scholar]
  6. Bircher J., Müller J., Guggenheim P., Haemmerli U. P. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet. 1966 Apr 23;1(7443):890–892. doi: 10.1016/s0140-6736(66)91573-x. [DOI] [PubMed] [Google Scholar]
  7. DAWSON A. M., McLAREN J., SHERLOCK S. Neomycin in the treatment of hepatic coma. Lancet. 1957 Dec 21;273(7008):1262–1268. [PubMed] [Google Scholar]
  8. Elkington S. G., Floch M. H., Conn H. O. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial. N Engl J Med. 1969 Aug 21;281(8):408–412. doi: 10.1056/NEJM196908212810803. [DOI] [PubMed] [Google Scholar]
  9. Fung W. P., Khoo O. T. Treatment of chronic hepatic encephalopathy with lactulose. Med J Aust. 1968 Jul 27;2(4):160–163. doi: 10.5694/j.1326-5377.1968.tb29379.x. [DOI] [PubMed] [Google Scholar]
  10. HAEMMERLI U. P., KISTLER H., AMMANN R., MARTHALER T., SEMENZA G., AURICCHIO S., PRADER A. ACQUIRED MILK INTOLERANCE IN THE ADULT CAUSED BY LACTOSE MALABSORPTION DUE TO A SELECTIVE DEFICIENCY OF INTESTINAL LACTASE ACTIVITY. Am J Med. 1965 Jan;38:7–30. doi: 10.1016/0002-9343(65)90156-7. [DOI] [PubMed] [Google Scholar]
  11. HAENEL H., FELDHEIM W., MULLERBEUTHOW W., RUTTLOFF H. Versuche zur Umstimmung der faecalen Flora des gesunden Erwachsenen, Eugalan-Topfer, Lactose, Lactulose-Sirup nach Petuely. Zentralbl Bakteriol Orig. 1958 Nov;173(1-2):76–96. [PubMed] [Google Scholar]
  12. HOFFMANN K., MOSSEL D. A., KORUS W., VAN DE KAMER J. H. UNTERSUCHUNGEN UEBER DIE WIRKUNGSWEISE DER LACTULOSE (BETA-GALACTOSIDO-FRUCTOSE) IM DARM. Klin Wochenschr. 1964 Feb 1;42:126–130. doi: 10.1007/BF01479054. [DOI] [PubMed] [Google Scholar]
  13. JACOBSON E. D., CHODOS R. B., FALOON W. W. An experimental malabsorption syndrome induced by neomycin. Am J Med. 1960 Apr;28:524–533. doi: 10.1016/0002-9343(60)90146-7. [DOI] [PubMed] [Google Scholar]
  14. LAWRENCE W., Jr, JACQUEZ J. A., DIENST S. G., POPPELL J. W., RANDALL H. T., ROBERTS K. E. The effect of changes in blood pH on the plasma total ammonia level. Surgery. 1957 Jul;42(1):50-9; discussion, 60. [PubMed] [Google Scholar]
  15. MACBETH W. A., KASS E. H., MCDERMOTT W. V., Jr TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS. Lancet. 1965 Feb 20;1(7382):399–403. doi: 10.1016/s0140-6736(65)90002-4. [DOI] [PubMed] [Google Scholar]
  16. Ma M. H., McLeod J. G., Blackburn C. R. Long-term treatment of portal-systemic encephalopathy with lactulose. Australas Ann Med. 1969 May;18(2):117–123. doi: 10.1111/imj.1969.18.2.117. [DOI] [PubMed] [Google Scholar]
  17. ORLOFF J., BERLINER R. W. The mechanism of the excretion of ammonia in the dog. J Clin Invest. 1956 Feb;35(2):223–235. doi: 10.1172/JCI103267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. PETUELY F. Der Bifidusfaktor. Dtsch Med Wochenschr. 1957 Nov 15;82(46):1957–1960. doi: 10.1055/s-0028-1117025. [DOI] [PubMed] [Google Scholar]
  19. PHEAR E. A., RUEBNER B. The in vitro production of ammonium and amines by intestinal bacteria in relation to nitrogen toxicity as a factor in hepatic coma. Br J Exp Pathol. 1956 Jun;37(3):253–262. [PMC free article] [PubMed] [Google Scholar]
  20. Paes I. C., Searl P., Rubert M. W., Faloon W. W. Intestinal lactase deficiency and saccharide malabsorption during oral neomycin administration. Gastroenterology. 1967 Jul;53(1):49–58. [PubMed] [Google Scholar]
  21. Resnick R. H., Ishihara A., Chalmers T. C., Schimmel E. M. A controlled trial of colon bypass in chronic hepatic encephalopathy. Gastroenterology. 1968 Jun;54(6):1057–1069. [PubMed] [Google Scholar]
  22. Rorsman G., Sulg I. Lactulose treatment of chronic hepatoportal encephalopathy. A clinical and electroencephalographic study. Acta Med Scand. 1970 May;187(5):337–346. doi: 10.1111/j.0954-6820.1970.tb02954.x. [DOI] [PubMed] [Google Scholar]
  23. Rottiers R., Van Egmond J., Verbruggen R., Dierick G., Vermeulen A., Standaert L., De Groote J., Demeulenaere L. Cirrhosis, hyperammonemia and Lactulose. Tijdschr Gastroenterol. 1968;11(2):123–139. [PubMed] [Google Scholar]
  24. SHORE P. A., BRODIE B. B., HOGBEN C. A. The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther. 1957 Mar;119(3):361–369. [PubMed] [Google Scholar]
  25. STABENAU J. R., WARREN K. S., RALL D. P. The role of pH gradient in the distribution of ammonia between blood and cerebrospinal fluid, brain and muscle. J Clin Invest. 1959 Feb;38(2):373–383. doi: 10.1172/JCI103811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Summerskill W. H., Aoyagi T., Evans W. B. Ammonia in the upper gastrointestinal tract of man: quantitations and relationships. Gut. 1966 Oct;7(5):497–501. doi: 10.1136/gut.7.5.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Treatment of chronic hepatic encephalopathy. Lancet. 1970 Aug 29;2(7670):449–450. [PubMed] [Google Scholar]
  28. WADDELL W. J., BUTLER T. C. The distribution and excretion of phenobarbital. J Clin Invest. 1957 Aug;36(8):1217–1226. doi: 10.1172/JCI103518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. WARREN K. S., NATHAN D. G. The passage of ammonia across the blood-brain-barrier and its relation to blood pH. J Clin Invest. 1958 Dec;37(12):1724–1728. doi: 10.1172/JCI103764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Walker J. G., Emlyn-Williams A., Rosenoer V. M., Craigie A., Agnew J. Treatment of chronic portal-systemic encephalopathy by surgical exclusion of the colon. Lancet. 1965 Oct 30;2(7418):861–866. doi: 10.1016/s0140-6736(65)92500-6. [DOI] [PubMed] [Google Scholar]
  31. Wesselius-De Casparis A., Braadbaart S., Bergh-Bohlken G. E., Mimica M. Treatment of chronic constipation with lactulose syrup: results of a double-blind study. Gut. 1968 Feb;9(1):84–86. doi: 10.1136/gut.9.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Zeegen R., Drinkwater J. E., Fenton J. C., Vince A., Dawson A. M. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy. Q J Med. 1970 Apr;39(154):245–263. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES